Statement Of Changes In Equity [Abstract]

BerGenBio - Filing #5877180

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through transactions with owners, equity
122,002,000 NOK
135,756,000 NOK
8,045,000 NOK
5,709,000 NOK
0 NOK
260,003,000 NOK
3,135,000 NOK
228,211,000 NOK
34,926,000 NOK
Reduction of issued capital
351,784,000 NOK
0 NOK
351,784,000 NOK
Share issue related cost
23,066,000 NOK
23,066,000 NOK
36,971,000 NOK
36,971,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.